Pharma News

Cytokinetics, Inc announced that data relating to patient baseline characteristics and the reasons for patient screen failure, both from the first cohort of the Phase 2 clinical trial of CK-2127107 in spinal muscular atrophy (SMA), were presented at the Cure SMA 2017 Annual SMA Conference in Orlando, FL by Stacy Rudnicki, M.D., Director, Clinical Research at Cytokinetics. In collaboration with Astellas Pharma Inc.Cytokinetics is developing CK-2127107 as a potential treatment for people living with SMA and certain other debilitating diseases and conditions associated with skeletal muscle weakness and/or fatigue.

Recro Pharma, Inc. a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the acquisition of exclusive global rights to two novel neuromuscular blocking agents (NMBs) and a proprietary chemical reversal agent from Cornell University.

The Central Drugs Standard Control Organization (CDSCO) has recommended Acellbia, the first rituximab biosimilar made in Russia, for approval in India.

In August 2017, BIOCAD will receive permanent market authorization in India, which represents a strategic milestone for BIOCAD’s international expansion

Glenmark Pharmaceuticals Europe (Glenmark) has been granted final approval by the MHRA (Medicines and Healthcare products Regulatory Agency) for Maloff Protect (250mg/100mg atovaquone/proguanil film-coated tablets), anti-malarial medication, as a pharmacy license in the United Kingdom.

New maximum prices for 814 programmed formulations were made effective with the NPPA drug price regulator setting the limit in sync with the new GST regime. These formulations include drugs used to treat cancer, HIV, diabetes and infections, among others.

Patients can continue to buy essential drugs in the MRP before the GST, ie not at the highest prices, until the new lots reach pharmacies and stockists, and reach the shelves.

Medical devices that are declared as "drugs", such as stents, valves, orthopedic implants, syringes and tools for operations, will now have to declare their retail maximum price (MRP) and other details including that of the manufacturer and the importer.

A recent survey on the state of label management in the pharmaceutical industry undertaken by NiceLabel in cooperation with Pharmaceutical Manufacturing revealsthe challenges facing pharmaceutical manufacturers as they try to produce accurate, compliant labels, and highlights the increasing importance of a single, integrated label management system.

Drug price regulator NPPA announced provisional maximum prices for 761 drugs, including anticancer drugs, HIV, diabetes and antibiotics, with a majority being reduced ahead of the GST implementation.

[adsense:336x280:8701650588]

Noncommunicable diseases (NCDs) kill 40 million people each year, says the World Health Organization (WHO). Noncommunicable diseases (NCDs), also known as chronic diseases, tend to be long-lasting and are the result of a combination of genetic, physiological, environmental and behavioral factors.